Detalhe da pesquisa
1.
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
; 22(12): 1503-1514, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716452
2.
Infection drives meningeal engraftment by inflammatory monocytes that impairs CNS immunity.
Nat Immunol
; 20(4): 407-419, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30886419
3.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470866
4.
Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand.
Emerg Infect Dis
; 28(11): 2214-2225, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220131
5.
Comparison of Outcomes After Treatment of Large Vessel Occlusion in a Critical Care Resuscitation Unit or a Neurocritical Care Unit.
Neurocrit Care
; 32(3): 725-733, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31452015
6.
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.
Front Immunol
; 15: 1339727, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38420129
7.
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Structure
; 32(2): 131-147.e7, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157856
8.
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Nat Commun
; 15(1): 200, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172512
9.
Humoral immune responses associated with control of SARS-CoV-2 breakthrough infections in a vaccinated US military population.
EBioMedicine
; 94: 104683, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37413891
10.
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies.
NPJ Vaccines
; 8(1): 43, 2023 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934088
11.
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity.
Nat Commun
; 14(1): 580, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737435
12.
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model.
Vaccines (Basel)
; 10(5)2022 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35632473
13.
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN.
Sci Adv
; 8(47): eade4433, 2022 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36417525
14.
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates.
Sci Transl Med
; 14(632): eabi5735, 2022 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914540
15.
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters.
bioRxiv
; 2021 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159328
16.
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates.
bioRxiv
; 2021 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791694
17.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
bioRxiv
; 2021 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851155
18.
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
NPJ Vaccines
; 6(1): 129, 2021 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711815